secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVAI BIO, INC. (AVAI)
CIK:        0001740797
Form:       8-K
Filed at:   2023-05-12T23:59:59+00:00
Accession:  0001740797-23-000037
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Trend Innovations engages Percy Kwong as Technology Advisor with quarterly stock compensation up to $250K
--------------------------------------------------------------------------------

- Advisor receives $150K/quarter in common stock (85% of 10-day VWAP, floor $0.10/share) for tech advisory services.
- If stock lists on Nasdaq, quarterly fee rises to $250K retroactive to April 15, 2023; term ends May 5, 2024 with possible renewal.
- Shares are unregistered; advisor is an accredited investor and bears own taxes; indemnification and insurance required from company.
- Advisor retains ownership of independent inventions and may continue work for other companies; agreement terminates for convenience.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1740797/000174079723000037/0001740797-23-000037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1740797/000174079723000037/tren8k_tech.htm
  HTML page:      https://secwatch.observer/filing/0001740797-23-000037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer